Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $17,451 | $15,053 | $14,063 | $13,527 |
| - Cash | $265 | $82 | $121 | $90 |
| + Debt | $153 | $189 | $146 | $104 |
| Enterprise Value | $17,340 | $15,160 | $14,088 | $13,541 |
| Revenue | $1,280 | $1,758 | $1,589 | $1,642 |
| % Growth | -27.2% | 10.7% | -3.3% | – |
| Gross Profit | $530 | $1,060 | $946 | $1,013 |
| % Margin | 41.4% | 60.3% | 59.5% | 61.7% |
| EBITDA | $654 | $368 | $434 | $605 |
| % Margin | 51.1% | 20.9% | 27.3% | 36.8% |
| Net Income | $377 | $133 | $250 | $377 |
| % Margin | 29.5% | 7.5% | 15.8% | 22.9% |
| EPS Diluted | 0.64 | 0.23 | 0.43 | 0.65 |
| % Growth | 178.3% | -46.5% | -33.8% | – |
| Operating Cash Flow | $549 | $430 | $238 | $324 |
| Capital Expenditures | -$103 | -$339 | -$211 | -$170 |
| Free Cash Flow | $446 | $91 | $27 | $155 |